Keyword Connections

aspergillosis

Journals

0

No Journal Connected

Research Groups

0

No Research Group Connected

Bibliographies

50

1 Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

2 Invasive Aspergillosis by : Epidemiology, Diagnosis, Antifungal Resistance, and Management.

3 Posaconazole achieves prompt recovery of voriconazole-induced liver injury in a case of invasive aspergillosis

4 Post-influenza aspergillosis, do not underestimate influenza B

5 Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations

6 Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections

7 Micafungin in the treatment of invasive candidiasis and invasive aspergillosis

8 The changes of expressive levels of IL-17A, STAT3, and RORγt in different invasive pulmonary aspergillosis mice

9 Posaconazole achieves prompt recovery of voriconazole-induced liver injury in a case of invasive aspergillosis

10 Post-influenza aspergillosis, do not underestimate influenza B

11 Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations

12 Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections

13 Micafungin in the treatment of invasive candidiasis and invasive aspergillosis

14 Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis.

15 Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.

16 Genetic polymorphisms in toll-like receptors 1, 2, and 4 in feline upper respiratory tract aspergillosis.

17 Invasive pulmonary aspergillosis in heart transplant recipients: Is mortality decreasing?

18 Successful Off-Label Use of Recombinant Factor VIIa and Coil Embolization in an Adolescent with Massive Hemoptysis Due to Invasive Pulmonary Aspergillosis

19 COVID-19-associated invasive pulmonary aspergillosis

20 Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study

21 Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT

22 Diphtheric aspergillosis tracheitis with gastrointestinal dissemination secondary to viral infections in a dairy calf.

23 pcr technology for detection of invasive aspergillosis

24 primary cutaneous aspergillosis

25 invasive aspergillosis involving multiple paranasal sinuses - a case report

26 common genetic polymorphisms within nfκb-related genes and the risk of developing invasive aspergillosis

27 chronic pulmonary aspergillosis in patients with underlying respiratory disorders in cuba—a pilot study

28 fatal case of probable invasive aspergillosis after five years of heart transplant: a case report and review of the literature

29 invasive pulmonary aspergillosis caused by aspergillus versicolor in a patient on mechanical ventilation

30 higher mortality of severe influenza patients with probable aspergillosis than those with and without other coinfections

31 primary cutaneous aspergillosis due to <i> aspergillus niger</i> in an immunocompetent patient

32 clinical and pathological correlation in pediatric invasive pulmonary aspergillosis

33 excellent outcome of aspergillous endophthalmitis in a case of allergic bronchopulmonary aspergillosis

34 correction: stewart, e.r.; thompson, g.r. treatment of primary pulmonary aspergillosis: an assessment of the evidence. j. fungi 2016, 2, 25.

35 invasive aspergillosis: results of multicenter study

36 salvage combination antifungal therapy for acute invasive aspergillosis may improve outcomes: a systematic review and meta-analysis

37 the many faces of pulmonary aspergillosis: imaging findings with pathologic correlation

38 early diagnosis and treatment of invasive aspergillosis as a main determinant of outcome – review of literature according to the presented case report

39 exogenous stimulation of type i interferon protects mice with chronic granulomatous disease from aspergillosis through early recruitment of host-protective neutrophils into the lung

40 chronic necrotizing pulmonary aspergillosis

41 allergic bronchopulmonary aspergillosis mimicking relapsing chronic eosinophilic pneumonia in non-asthma patient

42 invasive tracheobronchial aspergillosis in a child with acute myeloid leukemia

43 galactomannan, a surrogate marker for outcome in invasive aspergillosis: finally coming of age

44 Etiologic Agents and Diseases Found Associated with Clinical Aspergillosis in Falcons

45 Invasive aspergillosis in patients with hematological malignancies in the Czech and Slovak republics: Fungal InfectioN Database (FIND) analysis, 2005-2009.

46 Forum Report: Issues in the Design of Trials of Drugs for the Treatment of Invasive Aspergillosis

47 Intranasal granulocyte-macrophage colony-stimulating factor reduces the Aspergillus burden in an immunosuppressed murine model of pulmonary aspergillosis

48 New clinical algorithm including fungal biomarkers to better diagnose probable invasive pulmonary aspergillosis in ICU

49 Intranasal Granulocyte-Macrophage Colony-Stimulating Factor Reduces the Aspergillus Burden in an Immunosuppressed Murine Model of Pulmonary Aspergillosis

50 [Intralobar pulmonary sequestration presenting increased serum CEA, CA 19-9, and CA 125, and associated with asymptomatic pulmonary aspergillosis].